Clinical Development

The Clinical Development team at Oric Pharmaceuticals is responsible for designing, executing, and managing clinical trials to evaluate the safety and efficacy of the company's oncology therapies, including their lead asset, ORIC-101. This team collaborates closely with regulatory bodies, research organizations, and healthcare providers to ensure compliance with clinical standards and to advance the development of treatments that address mechanisms of cancer resistance. Team members play pivotal roles in driving the clinical strategy, overseeing trial operations, and analyzing data to inform future developmental decisions.